Kamal Pohar, MD
Urology · Cincinnati, OHNPI 1952350985
Payments from drug & device makers
Across 278 payments — averaging $12,189 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.6M
- Pfizer$287K
- F. Hoffmann-la Roche AG$163K
- Janssen Research & Development, LLC$96K
- E.r. Squibb & Sons, L.L.C.$72K
- Photocure Inc$68K
- plus $90K from 7 others
What the payments were for
- Consulting fees$14,81676%
- Speaking & faculty fees$2,50013%
- Travel & lodging$1,3567%
- Food & beverage$9195%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 189 | $2,613,739 |
| Pfizer | 13 | $286,538 |
| F. Hoffmann-la Roche AG | 18 | $162,619 |
| Janssen Research & Development, LLC | 7 | $96,245 |
| E.r. Squibb & Sons, L.L.C. | 8 | $72,230 |
| Photocure Inc | 18 | $67,502 |
| KARL Storz Endoscopy-america | 16 | $50,936 |
| Genentech, Inc. | 4 | $28,488 |
| Boehringer Ingelheim | 1 | $10,000 |
| Uroviu Corporation | 1 | $115 |
| Janssen Scientific Affairs, LLC | 1 | $72 |
| Urogen Pharma, Inc. | 1 | $42 |
| Covidien LP | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cysview$6,614
- N/A$1,572
- KEYTRUDA$1,206
- Uro-G Flexible Cystoscope$115
How this compares
$3,388,548 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Cincinnati
- Marc PliskinCincinnati$20.8M
- Martin FritzhandCincinnati$4.6M
- Abhinav SidanaCincinnati$334K
- Alberto MartiniCincinnati$145K
- Paurush BabbarCincinnati$140K
- Nilesh PatilCincinnati$80K
- Stephen BennettCincinnati$38K
- Lawrence GervasiMiddleburg Heights$4.7M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.